Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Acura Pharmaceuticals, Inc.    ACUR

SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Acura Pharmaceuticals, Inc. : Analysis Reports On Active Stocks: (NASDAQ: ACUR), (NYSE: SMFG)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/25/2013 | 07:40pm CEST

New York (April 25th, 2013) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) traded in the range of $2.56 and $2.74 during its latest trading session. The stock recorded the volume of 329,570 shares. Currently, it is at $2.68, up 3.67 from its previous close. Its average daily trading volume stands at 763,216 shares. Its MACD chart shows bullish trend. The company?s current market capitalization stands at $123.15 million.

Acura Pharmaceuticals stock has traded in the range of $1.06 and $4.50 in the past 52 weeks and has lost 17.13 percent of its value in the same time period. The stock has low volatility as its beta stands at 0.86.

Find out what could be next for ACUR here:

http://www.wallstreetscoop.net/market-scan/?symbol=ACUR


Sumitomo Mitsui Financial Group Inc. (NYSE: SMFG) stock is at $9.41, up 3.63 percent from its previous close of $9.08. The stock shows bullish trend as it made the up move with trading volume of 4.484 million shares, in contrast to the average daily trading volume of 2.044 million shares. Its bullish trend is further confirmed by its MACD chart and the stock is also trading in line with its 20 days SMA of $9.41.

Sumitomo Mitsui Financial stock is mildly volatile with its beta at 1.03. The company?s market capitalization is at $63.70 billion.

Find out more on SMFG here:

http://www.wallstreetscoop.net/market-scan/?symbol=SMFG

About Us:

WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.

WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetScoop.net

Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit: www.wallstreetscoop.net/disclaimer/

Contact Info:
Thomas Greene
Wall Street Scoop
info@wallstreetscoop.net
347-905-5009


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on ACURA PHARMACEUTICALS, INC
04/28 ACURA PHARMACEUTICALS : Indiana Governor's Bill Signing Ceremony Recognizes the ..
04/26 ACURA PHARMACEUTICALS : Receives Second U.S. Patent for Novel Limitx(TM) Abuse D..
04/21 ACURA PHARMACEUTICALS : to Host First Quarter 2016 Financial Results Conference ..
04/14 ACURA PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exhib..
04/13 ACURA PHARMACEUTICALS : Pharmaceutical's Limitx(TM) Technology Successfully Demo..
04/12 ACURA PHARMACEUTICALS : Announces FDA Fast Track Designation for the Development..
03/30 ACURA PHARMACEUTICALS' : Universal Shelf Registration Statement Declared Effecti..
03/14 ACURA PHARMACEUTICALS : Acknowledges Inclusion of Meth-Resistant Technology in I..
03/11 ACURA PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exhib..
03/08 ACURA PHARMACEUTICALS : to Present at the 28th Annual ROTH Conference
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials